Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Jade Biosciences, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 81
- +18 vs. Q4 2023
- Shares held
- 28.5M
- +282.4K (+1.0%) vs. Q4 2023
- Total value
- $841.5M
- +$203.9M (+32.0%) vs. Q4 2023
- New holders
- 22
- 19 more added
- Sold out
- 4
- 23 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 1 | $0 | 0.00% | +1 | New |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 2 | $59 | 0.00% | +2 | New |
| Nisa Investment Advisors, LLC | 7 | $207 | 0.00% | +7 | New |
| Russell Investments Group, Ltd. | 7 | $207 | 0.00% | +7 | New |
| Federated Hermes, Inc. | 60 | $1.77K | 0.00% | +60 | New |
| GAMMA Investing LLC | 94 | $2.78K | 0.00% | +14+17.5% | Added |
| Royal Bank of Canada | 287 | $8.00K | 0.00% | −3,188−91.7% | Reduced |
| Amalgamated Bank | 347 | $10.0K | 0.00% | −1,085−75.8% | Reduced |
| Fortitude Family Office, LLC | 416 | $12.3K | 0.01% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 701 | $20.7K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 772 | $22.8K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 1,124 | $33.2K | 0.00% | −716−38.9% | Reduced |
| Legal & General Group Plc | 1,177 | $34.8K | 0.00% | −489−29.4% | Reduced |
| Tower Research Capital LLC (TRC) | 2,060 | $60.9K | 0.00% | +1,138+123.4% | Added |
| STRS Ohio | 2,200 | $65.0K | 0.00% | −100−4.3% | Reduced |
| Citigroup Inc | 2,547 | $75.3K | 0.00% | +452+21.6% | Added |
| EntryPoint Capital, LLC | 3,126 | $92.4K | 0.08% | −3,007−49.0% | Reduced |
| Wells Fargo & Company | 3,362 | $99.4K | 0.00% | +448+15.4% | Added |
| New York State Common Retirement Fund | 4,312 | $127.5K | 0.00% | +9+0.2% | Added |
| JPMorgan Chase & Co | 4,591 | $135.8K | 0.00% | −2,885−38.6% | Reduced |
| Quest Partners LLC | 4,626 | $136.8K | 0.02% | +4,626 | New |
| Deutsche Bank AG | 4,779 | $141.3K | 0.00% | −206−4.1% | Reduced |
| MetLife Investment Management | 5,228 | $154.6K | 0.00% | 00.0% | Unchanged |
| American International Group, Inc. | 5,509 | $162.9K | 0.00% | −47−0.8% | Reduced |
| American Century Companies Inc | 7,124 | $210.7K | 0.00% | +7,124 | New |
| Renaissance Technologies LLC | 7,500 | $222.0K | 0.00% | +7,500 | New |
| Two Sigma Advisers, LP | 7,800 | $230.6K | 0.00% | +7,800 | New |
| Barclays PLC | 7,872 | $232.8K | 0.00% | −7,522−48.9% | Reduced |
| Bank of America Corp | 8,917 | $263.7K | 0.00% | −13,781−60.7% | Reduced |
| Jump Financial, LLC | 9,600 | $283.9K | 0.01% | +9,600 | New |
| UBS Group AG | 11,237 | $332.3K | 0.00% | −1,004−8.2% | Reduced |
| Jane Street Group, LLC | 11,264 | $333.1K | 0.00% | −1,842−14.1% | Reduced |
| PDT Partners, LLC | 12,680 | $374.9K | 0.04% | +12,680 | New |
| Alliancebernstein L.P. | 13,100 | $387.4K | 0.00% | 00.0% | Unchanged |
| Takeda Pharmaceutical Co Ltd | 13,580 | $401.6K | 0.14% | 00.0% | Unchanged |
| Rhumbline Advisers | 14,622 | $432.4K | 0.00% | +465+3.3% | Added |
| Dimensional Fund Advisors LP | 14,957 | $442.3K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 15,900 | $470.2K | 0.13% | +15,900 | New |
| D. E. Shaw & Co., Inc. | 17,265 | $510.5K | 0.00% | +17,265 | New |
| Parkwood LLC | 17,728 | $524.0K | 0.06% | +1,942+12.3% | Added |
| Alps Advisors Inc | 19,519 | $577.2K | 0.00% | +801+4.3% | Added |
| Prelude Capital Management, LLC | 20,685 | $611.7K | 0.04% | +20,685 | New |
| Two Sigma Investments, LP | 22,913 | $677.5K | 0.00% | +13,153+134.8% | Added |
| Shay Capital LLC | 24,588 | $727.1K | 0.21% | +24,588 | New |
| Morgan Stanley | 26,283 | $777.2K | 0.00% | −8,769−25.0% | Reduced |
| Bank of New York Mellon Corp | 27,664 | $818.0K | 0.00% | −8,894−24.3% | Reduced |
| Charles Schwab Investment Management Inc | 30,958 | $915.4K | 0.00% | +1,416+4.8% | Added |
| Nuveen Asset Management, LLC | 40,047 | $1.18M | 0.00% | 00.0% | Unchanged |
| Fred Alger Management, LLC | 43,790 | $1.29M | 0.01% | +7,312+20.0% | Added |
| Skandinaviska Enskilda Banken AB (publ) | 44,320 | $1.31M | 0.01% | −6,546−12.9% | Reduced |
| Nan Fung Group Holdings Ltd | 47,936 | $1.42M | 1.31% | 00.0% | Unchanged |
| Eversept Partners, LP | 54,150 | $1.60M | 0.12% | +3,908+7.8% | Added |
| Walleye Capital LLC | 54,520 | $1.61M | 0.02% | +54,520 | New |
| Millennium Management LLC | 62,555 | $1.85M | 0.00% | +62,555 | New |
| Nantahala Capital Management, LLC | 91,188 | $2.70M | 0.26% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 97,842 | $2.89M | 0.09% | +97,842 | New |
| Exome Asset Management LLC | 98,485 | $2.91M | 2.49% | +98,485 | New |
| Northern Trust Corp | 98,559 | $2.91M | 0.00% | −968−1.0% | Reduced |
| Superstring Capital Management LP | 110,264 | $3.26M | 2.16% | +110,264 | New |
| Woodline Partners LP | 200,000 | $5.91M | 0.05% | +200,000 | New |
| Ghost Tree Capital, LLC | 225,000 | $6.65M | 2.14% | +15,000+7.1% | Added |
| State Street Corp | 229,986 | $6.80M | 0.00% | +15,959+7.5% | Added |
| Ensign Peak Advisors, Inc | 262,257 | $7.75M | 0.01% | +140,000+114.5% | Added |
| Geode Capital Management, LLC | 281,760 | $8.33M | 0.00% | +4,865+1.8% | Added |
| Ikarian Capital, LLC | 367,965 | $10.9M | 2.96% | +367,965 | New |
| Point72 Asset Management, L.P. | 399,824 | $11.8M | 0.03% | −41,650−9.4% | Reduced |
| Octagon Capital Advisors LP | 403,685 | $11.9M | 1.45% | 00.0% | Unchanged |
| Eventide Asset Management, LLC | 445,500 | $13.2M | 0.21% | +433,322+3,558.2% | Added |
| FMR LLC | 537,530 | $15.9M | 0.00% | +440.0% | Added |
| OrbiMed Advisors LLC | 565,374 | $16.7M | 0.33% | −191,556−25.3% | Reduced |
| Vanguard Group Inc | 672,275 | $19.9M | 0.00% | +45,444+7.2% | Added |
| BlackRock Inc. | 709,752 | $21.0M | 0.00% | −17,702−2.4% | Reduced |
| Driehaus Capital Management LLC | 794,992 | $23.5M | 0.23% | −263,217−24.9% | Reduced |
| Great Point Partners LLC | 887,690 | $26.2M | 4.09% | −150,000−14.5% | Reduced |
| Cormorant Asset Management, LP | 1,069,796 | $31.6M | 1.39% | −141,900−11.7% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,204,867 | $35.6M | 1.50% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 1,680,517 | $49.7M | 0.62% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $60.3M | 5.57% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 2,201,274 | $65.1M | 5.15% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $111.1M | 6.56% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 8,263,982 | $244.4M | 3.11% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −143,235−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −103,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −9,433−100.0% | Sold out |
| Golden State Equity Partners | – | – | – | – | Not filed |